These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1394 related articles for article (PubMed ID: 17460447)
1. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
2. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969 [TBL] [Abstract][Full Text] [Related]
3. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124 [TBL] [Abstract][Full Text] [Related]
4. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034 [TBL] [Abstract][Full Text] [Related]
5. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420 [TBL] [Abstract][Full Text] [Related]
7. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
8. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796 [TBL] [Abstract][Full Text] [Related]
9. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
10. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304 [TBL] [Abstract][Full Text] [Related]
11. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Meriden Z; Yemelyanova AV; Vang R; Ronnett BM Am J Surg Pathol; 2011 Feb; 35(2):276-88. PubMed ID: 21263249 [TBL] [Abstract][Full Text] [Related]
12. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports. Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281 [TBL] [Abstract][Full Text] [Related]
13. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
14. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780 [TBL] [Abstract][Full Text] [Related]
15. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Cao D; Ji H; Ronnett BM Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919 [TBL] [Abstract][Full Text] [Related]
16. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations. Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818 [TBL] [Abstract][Full Text] [Related]
17. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms. Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113 [TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Ferguson AW; Svoboda-Newman SM; Frank TS Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417 [TBL] [Abstract][Full Text] [Related]
19. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Young RH Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813 [TBL] [Abstract][Full Text] [Related]
20. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. McCluggage WG; Jenkins D Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]